Open AccessUse of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States
Author(s) -
Julia L. Marcus,
Jonathan M. Snowden,
Mara E. Murray Horwitz,
Sengwee Toh,
Casie Horgan,
Rong Chen Tilney,
Rajani Rajbhandari,
Soowoo Back,
Daniel Westreich
Publication year - 2019
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz791
Subject(s) - medicine , human immunodeficiency virus (hiv) , levonorgestrel , intrauterine device , family planning , obstetrics , gynecology , virology , population , research methodology , environmental health
Concerns have been raised about progestin-containing contraceptives and the risk of human immunodeficiency virus (HIV) acquisition. Based on health insurance data from women in the United States with intrauterine device (IUD) insertions during 2011-2018, there was no increased risk of incident HIV diagnosis for levonorgestrel-releasing IUDs versus copper IUDs.